Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Skin Toxicities”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06441266
What this trial is testing

M-PART in Head and Neck Cancer Patients Treated With KeraStat Cream for Acute Radiation Dermatitis

Who this might be right for
Radiation Dermatitis
Wake Forest University Health Sciences 16
Not applicableUnknownNCT03033186
What this trial is testing

Everolimus TDM to Predict Long Term Toxicity

Who this might be right for
Breast CancerRenal Cell CarcinomaPancreatic Neuroendocrine Tumour+2 more
Maastricht University Medical Center 40
Testing effectiveness (Phase 2)Study completedNCT00436566
What this trial is testing

Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery

Who this might be right for
Breast CancerCardiac Toxicity
Mayo Clinic 122
Testing effectiveness (Phase 2)Ended earlyNCT02096588
What this trial is testing

Detection and Prevention of Anthracycline-Related Cardiac Toxicity With Concurrent Simvastatin

Who this might be right for
Breast CancerStage I Breast CancerStage II Breast Cancer+1 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 34
Testing effectiveness (Phase 2)WithdrawnNCT02319616
What this trial is testing

Topical Clobetasol for the Treatment of Toxic Epidermal Necrolysis

Who this might be right for
Toxic Epidermal Necrolysis
University of California, Davis
Not applicableStudy completedNCT01015326
What this trial is testing

Development of Dermatology-related Quality of Life Assessment in Patients Treated With Epidermal Growth Factor Receptor (EGFR) Inhibitors

Who this might be right for
Skin Toxicities
Northwestern University 32
Not applicableStudy completedNCT01621425
What this trial is testing

Lean Body Mass as a Determinant of Docetaxel Pharmacokinetics and Toxicity

Who this might be right for
Breast CancerMetastatic Castration-resistant Prostate Carcinoma
Radboud University Medical Center 25
Post-approval studies (Phase 4)Study completedNCT02739295
What this trial is testing

G-CSF in the Treatment of Toxic Epidermal Necrolysis

Who this might be right for
Stevens - Johnson Syndrome
University of Liege 10
Not applicableStudy completedNCT02388230
What this trial is testing

Quantification of Breast RadioTherapy Associated Late Toxicity Using Novel UltraSound Techniques

Who this might be right for
Breast Radiotherapy Toxicity
Institute of Cancer Research, United Kingdom 16
Not applicableStudy completedNCT01948726
What this trial is testing

Hypofractionation With Simultaneous Integrated Boost for Early Breast Cancer

Who this might be right for
Breast Cancer After Breast Conserving Surgery Indicating Postoperative Radiotherapy With Boost
University Hospital Schleswig-Holstein 150
Not applicableStudy completedNCT01727011
What this trial is testing

Single Fraction Elderly Breast Irradiation (SiFEBI)

Who this might be right for
Breast Cancer
Centre Antoine Lacassagne 37
Not applicableLooking for participantsNCT06826885
What this trial is testing

Safety and Efficacy of IMPT or IMRT for Breast Cancer

Who this might be right for
Breast CancerProton TherapyIntensity Modulated Radiation Therapy+2 more
Ruijin Hospital 500
Not applicableActive Not RecruitingNCT02290782
What this trial is testing

TARGIT-C(Consolidation) Prospective Phase IV Study of IORT in Patients With Small Breast Cancer

Who this might be right for
Breast Cancer
Universitätsmedizin Mannheim 387
Not applicableStudy completedNCT03948724
What this trial is testing

Impact of Therapeutic Patient Education on the Toxicity of Immune Checkpoint Inhibitors in Oncology

Who this might be right for
Therapeutic Patient EducationImmune Checkpoint InhibitorsMelanoma+4 more
Institut Cancerologie de l'Ouest 412
Testing effectiveness (Phase 2)Ended earlyNCT01301040
What this trial is testing

Early Cardiac Toxicity of Adjuvant CT in Elderly BC.

Who this might be right for
Breast Cancer
Jules Bordet Institute 2
Large-scale testing (Phase 3)Study completedNCT00438659
What this trial is testing

Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in Situ

Who this might be right for
Breast CancerDermatologic ComplicationsRadiation Toxicity+1 more
North Central Cancer Treatment Group 176
Not applicableLooking for participantsNCT05933733
What this trial is testing

Oncologic Outcomes and Toxicities of Salvage Treatment in Patients With Locoregionally Recurrent Breast Cancer

Who this might be right for
Breast Cancer
Samsung Medical Center 190
Large-scale testing (Phase 3)Active Not RecruitingNCT06062810
What this trial is testing

Bioequivalence ANDA SNP Clinical Study - Raloxifene and Single Nucleotide Polymorphisms

Who this might be right for
Breast Cancer
Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair 600
Not applicableStudy completedNCT00886535
What this trial is testing

Effect of Pharmacogenomics Differences in Phase I and II Metabolism of Tamoxifen on Efficacy and Toxicity

Who this might be right for
Breast CancerDuctal Carcinoma in Situ
Milton S. Hershey Medical Center 41
Early research (Phase 1)Study completedNCT00001676
What this trial is testing

Cyclophosphamide and Fludarabine to Treat Lupus Nephritis

Who this might be right for
GlomerulonephritisLupus NephritisSystemic Lupus Erythematosus
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 15
Next Page